Member access

4-Traders Homepage  >  Shares  >  Nyse  >  National Health Investors Inc    NHI   US63633D1046

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
National Health Investors  : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales78,482,797,0106114-
Operating income (EBITDA)68,974,090,2103116-
Operating profit (EBIT)57,962,073,276,680,8-
Pre-Tax Profit (EBT)------
Net income69,481,190,774,486,8-
EPS ( $)2,502,923,262,733,28-
Dividend per Share ( $)2,362,722,862,873,01-
Yield3,99%4,59%4,83%4,84%5,08%-
Announcement Date02/17/2011
11:30am
02/15/2012
10:11pm
02/14/2013
09:36pm
---
Finances - Leverage
National Health Investors  : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt35,1-----
Finance------
Operating income (EBITDA)68,974,090,2103116-
Leverage
(Debt/EBITDA)
0,51x-----
Capital Expenditure98,775,8-1,09--
Book Value Per Share (BVPS)16,0 $16,0 $----
Cash Flow per Share--3,10 $3,42 $3,57 $-
Announcement Date02/17/2011
11:30am
02/15/2012
10:11pm
02/14/2013
09:36pm
---
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 1 650 M$ -
Company Value - 1 650 M$
Valuation 2013e 2014e
PER (Price / EPS) 21,7x 18,0x
Capitalization / Revenue 15,6x 14,4x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) 4,84% 5,08%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 72,6% 70,6%
operating laverage (Delta EBIT / Delta Sales) 0,52x 0,65x
Net Margin (Net Profit / Revenue) 70,5% 75,8%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend 105% 91,8%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   1,03% -
Cash Flow / Sales (Taux d'autofinancement) 90,3% 86,9%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
National Health Investors  : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.